Healthpeak Properties Aktie 50880191 / US42250P1030
16.52
USD
0.14
USD
0.85 %
02.04.2026
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Healthpeak Properties Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Healthpeak Properties Inc Registered Shs | 7.59 | 1.22 | USD |
| 2024 | Healthpeak Properties Inc Registered Shs | 5.92 | 1.20 | USD |
| 2023 | Healthpeak Properties Inc Registered Shs | 6.06 | 1.20 | USD |
| 2022 | Healthpeak Properties Inc Registered Shs | 4.79 | 1.20 | USD |
| 2021 | Healthpeak Properties Inc Registered Shs | 3.33 | 1.20 | USD |
| 2020 | Healthpeak Properties Inc Registered Shs | 4.90 | 1.48 | USD |
| 2019 | Healthpeak Properties Inc Registered Shs | 4.29 | 1.48 | USD |
| 2018 | Healthpeak Properties Inc Registered Shs | 5.30 | 1.48 | USD |
| 2017 | Healthpeak Properties Inc Registered Shs | 5.67 | 1.48 | USD |
| 2016 | Healthpeak Properties Inc Registered Shs | 7.05 | 2.10 | USD |
Gewinn je Aktie- Healthpeak Properties
| 0.1 25 | 0.4 24 | 0.6 23 | 0.9 22 | 0.9 21 | 0.8 20 | 0.1 19 |
Umsatz je Aktie- Healthpeak Properties
| 4.1 25 | 4.0 24 | 4.0 23 | 3.8 22 | 3.5 21 | 3.1 20 | 4.1 19 |
KGV- Healthpeak Properties
| 159 25 | 56.5 24 | 35.6 23 | 27.2 22 | 222 21 | 383 19 |
Healthpeak Properties Inc Registered Shs: Die Aktie (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 0.10 | 0.36 | 0.56 | 0.92 | 0.93 | 0.77 | 0.09 |
| Gewinn je Aktie (unverwässert) | 0.10 | 0.36 | 0.56 | 0.92 | 0.16 | -0.09 | 0.09 |
| Gewinn je Aktie (verwässert) | 0.10 | 0.36 | 0.56 | 0.92 | 0.16 | -0.09 | 0.09 |
| Dividende je Aktie | 1.22 | 1.20 | 1.20 | 1.20 | 1.20 | 1.48 | 1.48 |
| Veränderung Dividende je Aktie in % | 1.67 | 0.00 | 0.00 | 0.00 | -18.92 | 0.00 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 849.10 | 794.78 | 657.02 | 649.36 | 650.08 | 787.07 | 720.12 |
Healthpeak Properties Inc Registered Shs: Unternehmenskennzahlen (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 4.06 | 3.99 | 3.99 | 3.82 | 3.52 | 3.10 | 4.08 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 158.74 | 56.53 | 35.61 | 27.23 | 222.23 | - | 383.43 |
| KGV (Jahresendkurs, Gewinn verwässert) | 158.74 | 56.53 | 35.61 | 27.23 | 222.23 | - | 383.43 |
| Dividendenrendite Jahresende in % | 7.59 | 5.92 | 6.06 | 4.79 | 3.33 | 4.90 | 4.29 |
| Eigenkapitalquote in % | 40.83 | 45.43 | 44.11 | 46.21 | 46.84 | 46.13 | 47.51 |
| Fremdkapitalquote in % | 59.17 | 54.57 | 55.89 | 53.79 | 53.16 | 53.87 | 52.49 |
Healthpeak Properties Inc Registered Shs: GuV (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 2’822.51 | 2’700.45 | 2’181.00 | 2’061.18 | 1’896.18 | 1’644.88 | 1’997.38 |
| Umsatzveränderung in % | 4.52 | 23.82 | 5.81 | 8.70 | 15.28 | -17.65 | 8.20 |
| Bruttoergebnis vom Umsatz | 634.55 | 568.38 | 529.04 | 487.62 | 438.62 | 308.39 | 458.02 |
| Bruttoergebnisveränderung in % | 11.64 | 7.44 | 8.50 | 11.17 | 42.23 | -32.67 | -22.65 |
| Operatives Ergebnis | 545.03 | 461.24 | 439.51 | 349.58 | 317.16 | 172.24 | 139.12 |
| Veränderung Operatives Ergebnis in % | 18.16 | 4.94 | 25.73 | 10.22 | 84.14 | 23.81 | -68.40 |
| Ergebnis vor Steuern | 284.29 | 273.17 | 314.94 | 507.13 | 128.37 | 217.68 | 51.42 |
| Veränderung Ergebnis vor Steuern in % | 4.07 | -13.26 | -37.90 | 295.06 | -41.03 | 323.31 | -95.14 |
| Ergebnis nach Steuer | 70.51 | 242.38 | 304.28 | 496.25 | 531.33 | 143.70 | 43.99 |
| Veränderung Ergebnis nach Steuer in % | -70.91 | -20.34 | -38.68 | -6.60 | 269.76 | 226.68 | -95.84 |
Healthpeak Properties Inc Registered Shs: Bilanz (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 12’034 | 10’881 | 8’774 | 8’483 | 8’111 | 8’576 | 7’365 |
| Langzeit Gesamtverbindlichk. je Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 8’302 | 9’058 | 6’925 | 7’288 | 7’146 | 7’345 | 6’667 |
| Veränderung Eigenkapital in % | -10.73 | 32.29 | -4.57 | 2.14 | -4.02 | 11.56 | 2.37 |
| Bilanzsumme | 20’336 | 19’938 | 15’699 | 15’771 | 15’258 | 15’920 | 14’033 |
| Veränderung Bilanzsumme in % | 1.99 | 27.00 | -0.46 | 3.37 | -4.16 | 13.45 | 10.33 |
Healthpeak Properties Inc Registered Shs: Sonstige Angaben (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 0.10 | 0.36 | 0.56 | 0.92 | 0.16 | -0.09 | 0.09 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -71.76 | -35.52 | -39.62 | 467.36 | - | -202.10 | -95.98 |
| Gewinn je Aktie (verwässert) | 0.10 | 0.36 | 0.56 | 0.92 | 0.16 | -0.09 | 0.09 |
| Veränderung Gewinn je Aktie (verwässert) in % | -71.75 | -35.50 | -39.62 | 467.00 | - | -202.78 | -95.96 |
| Anzahl Mitarbeiter | 411 | 387 | 193 | 199 | 196 | 217 | 204 |
| Veränderung Anzahl Mitarbeiter in % | 6.20 | 100.52 | -3.02 | 1.53 | -9.68 | 6.37 | 1.49 |
Healthpeak Properties Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Healthpeak Properties Inc Registered Shs | Quartalszahlen | 23.04.2026 |
| Healthpeak Properties Inc Registered Shs | Quartalszahlen | 23.07.2026 |
| Healthpeak Properties Inc Registered Shs | Quartalszahlen | 22.10.2026 |
| Healthpeak Properties Inc Registered Shs | Quartalszahlen | 08.02.2027 |
Healthpeak Properties Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2025 Earnings Release | 02.02.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 23.10.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 24.07.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 24.04.2025 |
| Hauptversammlung | Annual General Meeting | 24.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 03.02.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 24.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 25.07.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 25.04.2024 |
| Hauptversammlung | Annual General Meeting | 25.04.2024 |
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 204 | 217 | 196 | 199 | 193 |
| Umsatz pro Mitarbeiter in Mio. EUR | 9.79 | 7.58 | 9.67 | 10.36 | 11.30 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 939 | 2’975 | 713 | 605 | 561 |
| Summe Anlagevermögen | 13’094 | 12’945 | 14’544 | 15’166 | 15’138 |
| Summe Aktiva | 14’033 | 15’920 | 15’258 | 15’771 | 15’699 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7’365 | 8’576 | 8’111 | 8’483 | 8’774 |
| Summe Eigenkapital | 6’667 | 7’345 | 7’146 | 7’288 | 6’925 |
| Summe Passiva | 14’033 | 15’920 | 15’258 | 15’771 | 15’699 |
Adresse
| 4600 South Syracuse Street, 80237-5050 Denver | |
| Telefon | +1 (720) 428-5050 |
| URL | https://www.healthpeak.com/ |
Management
|
Adam G. Mabry
Chief Investment Officer |
|
Andrew W. Johns
Senior Vice President-Investor Relations |
|
Ankit B. Patadia
Treasurer, Head-Finance & Capital Markets |
|
Ava E. Lias-Booker
Independent Director |
|
Brian G. Cartwright
Independent Director |
|
Carol B. Samaan
Secretary, Senior VP & Deputy General Counsel |
|
Denis J. Sullivan
MD-Lab Investments & San Diego Market |
|
James B. Connor
Independent Director |
|
John T. Thomas
Vice Chairman |
|
Katherine Mary Sandstrom
Chairman |
|
Kelvin Moses
Chief Financial Officer |
|
Lisa A. Alonso
Chief Human Resources Officer & Executive VP |
|
Mark D. Theine
Senior Vice President-Outpatient Medical |
|
Pamela J. Shelley-Kessler
Independent Director |
|
R. Kent Griffin
Independent Director |
|
Richard A. Weiss
Independent Director |
|
Sara Grootwassink Lewis
Independent Director |
|
Scott M. Brinker
President, Chief Executive Officer & Director |
|
Scott R. Bohn
Chief Development Officer & Head-Lab |
|
Shawn G. Johnston
Chief Accounting Officer & Executive VP |
|
Tommy George Thompson
Independent Director |
|
Tracy A. Porter
Executive Vice President & General Counsel |